Drug Shortage Report for ESTRING

Last updated on 2024-04-24 History
Report ID 201581
Drug Identification Number 02168898
Brand name ESTRING
Common or Proper name Estring
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ESTRADIOL
Strength(s) 2MG
Dosage form(s) RING (SLOW-RELEASE)
Route of administration VAGINAL VAGINAL
Packaging size 1ea
ATC code G03CA
ATC description ESTROGENS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-08-10
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2024-04-24
Company comments Next partial availability toward end of June, inventory will remain under allocation, . For more information: Paladin Toll Free: 1-866-340-1112 Paladin Fax: 1-866-340-7221 Email: customerservicepaladin@paladinlabs.com
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2024-04-24 French Compare
v16 2024-04-24 English Compare
v15 2024-03-13 French Compare
v14 2024-03-13 English Compare
v13 2024-03-13 English Compare
v12 2024-01-12 French Compare
v11 2024-01-12 English Compare
v10 2024-01-12 French Compare
v9 2024-01-12 English Compare
v8 2024-01-12 English Compare
v7 2023-12-06 French Compare
v6 2023-12-06 English Compare
v5 2023-10-10 French Compare
v4 2023-10-10 English Compare
v3 2023-08-11 English Compare
v2 2023-08-10 French Compare
v1 2023-08-10 English Compare

Showing 1 to 17 of 17